Skull Base 2011; 21(4): 277-278
DOI: 10.1055/s-0031-1275261
LETTER TO THE EDITOR

© Thieme Medical Publishers

On “Clivus Chordoma: Is It Enough to Image the Primary Site?” (Skull Base 2010;20:111–113)

Takehiko Yamaguchi1
  • 1Department of Pathology, Jichi Medical University, Tochigi, Japan
Further Information

Publication History

Publication Date:
21 March 2011 (online)

I read the case report entitled “Clivus Chordoma: Is It Enough to Image the Primary Site?” with great interest.[1] Unfortunately, imaging and histological descriptions are not enough to know the details of the lesions, although it may depend on regulation of the instruction form for submission of articles. However, I wonder if the second lesion in the fifth lumbar vertebral body could be benign. The lesion is completely asymptomatic and was found on magnetic resonance imaging (MRI). The lesion exhibits high signal intensity on T2-weighted images and seems to be located within the vertebra. These limited but peculiar features are characteristic of benign notochordal cell tumor (BNCT).[2] [3] BNCT is a recently recognized benign counterpart of chordoma and is characterized by intraosseous proliferation of benign notochordal cells. X-ray often fails to demonstrate a lesion or shows vague sclerosis or ivory vertebra occasionally. Computed tomography reveals osteosclerosis within bone in addition to no bone destruction or extraosseous tumor extension. MRI reveals low signal intensity on T1-weighted images, high on T2-weighted images, and no contrast enhancement on gadolinium-diethyltriaminepentaacetic acid T1-weighted images. Bone scan usually fails to demonstrate any abnormal uptake. Histologically, BNCT tends to be misdiagnosed as chordoma. The lesion consists of sheets of adipocyte-like vacuolated cells combined with less vacuolated cells. The lesion lacks significant nuclear atypia and intercellular myxoid background. Mitotic figures are not seen. It is not rare to have more than one lesion at the different anatomic level of axial skeleton, and lesions are often found in patients with chordoma.[4] BNCT does not require any surgical treatment. Only follow-up examinations are necessary because malignant transformation to chordoma may occur.[5] The authors do not seem to pay attention to the possibility of BNCT. The patients with multiple chordomas are documented; however, synchronous development of chordoma is very rare.[6] To prevent unnecessary treatment, the differential diagnosis between chordoma and BNCT should be made carefully when another lesion is found during a general skeletal survey for chordoma patients.

REFERENCES

  • 1 Ahmed S K, Murata H, Draf W. Clivus chordoma: is it enough to image the primary site?.  Skull Base. 2010;  20 111-113
  • 2 Yamaguchi T, Suzuki S, Ishiiwa H, Ueda Y. Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas?.  Histopathology. 2004;  44 597-602
  • 3 Yamaguchi T, Iwata J, Sugihara S et al.. Distinguishing benign notochordal cell tumors from vertebral chordoma.  Skeletal Radiol. 2008;  37 291-299
  • 4 Deshpande V, Nielsen G P, Rosenthal D I, Rosenberg A E. Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma.  Am J Surg Pathol. 2007;  31 1573-1577
  • 5 Yamaguchi T, Watanabe-Ishiiwa H, Suzuki S, Igarashi Y, Ueda Y. Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors.  Mod Pathol. 2005;  18 1005-1010
  • 6 Anderson W B, Meyers H I. Multicentric chordoma. Report of a case.  Cancer. 1968;  21 126-128

Takehiko YamaguchiM.D. Ph.D. 

Associate Professor, Department of Pathology, Jichi Medical University

3311-1 Yakushiji, Shimotsuke 329-0498, Tochigi, Japan

Email: takehiko@jichi.ac.jp

    >